These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36247896)

  • 21. Deep brain stimulation in a young child with
    Fung EL; Mo CY; Fung ST; Chan AY; Lau KY; Chan EK; Chan DY; Zhu XL; Chan DT; Poon WS
    Surg Neurol Int; 2022; 13():285. PubMed ID: 35855141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Phenotype of De Novo
    Talvik I; Møller RS; Vaher M; Vaher U; Larsen LH; Dahl HA; Ilves P; Talvik T
    Child Neurol Open; 2015; 2(2):2329048X15583717. PubMed ID: 28503590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent GNAO1 Mutations Associated With Developmental Delay and a Movement Disorder.
    Menke LA; Engelen M; Alders M; Odekerken VJ; Baas F; Cobben JM
    J Child Neurol; 2016 Dec; 31(14):1598-1601. PubMed ID: 27625011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical whole-exome sequencing reveals a novel missense pathogenic variant of GNAO1 in a patient with infantile-onset epilepsy.
    Law CY; Chang ST; Cho SY; Yau EK; Ng GS; Fong NC; Lam CW
    Clin Chim Acta; 2015 Dec; 451(Pt B):292-6. PubMed ID: 26485252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive Movement Disorder in Brothers Carrying a GNAO1 Mutation Responsive to Deep Brain Stimulation.
    Kulkarni N; Tang S; Bhardwaj R; Bernes S; Grebe TA
    J Child Neurol; 2016 Feb; 31(2):211-4. PubMed ID: 26060304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbamazepine-, Oxcarbazepine-, Eslicarbazepine-Associated Movement Disorder: A Literature Review.
    Rissardo JP; Caprara ALF
    Clin Neuropharmacol; 2020; 43(3):66-80. PubMed ID: 32384309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zinc for GNAO1 encephalopathy: Preclinical profiling and a clinical case.
    Larasati YA; Thiel M; Koval A; Silachev DN; Koy A; Katanaev VL
    Med; 2024 Aug; ():. PubMed ID: 39153472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GNAO1 encephalopathy: further delineation of a severe neurodevelopmental syndrome affecting females.
    Marcé-Grau A; Dalton J; López-Pisón J; García-Jiménez MC; Monge-Galindo L; Cuenca-León E; Giraldo J; Macaya A
    Orphanet J Rare Dis; 2016 Apr; 11():38. PubMed ID: 27072799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype-phenotype correlation and treatment effects in young patients with
    Thiel M; Bamborschke D; Janzarik WG; Assmann B; Zittel S; Patzer S; Auhuber A; Opp J; Matzker E; Bevot A; Seeger J; van Baalen A; Stüve B; Brockmann K; Cirak S; Koy A
    J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):806-815. PubMed ID: 37225406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of early-onset epileptic encephalopathy with involuntary movements - Case series and literature review.
    Arisaka A; Nakashima M; Kumada S; Inoue K; Nishida H; Mashimo H; Kashii H; Kato M; Maruyama K; Okumura A; Saitsu H; Matsumoto N; Fukuda M
    Epilepsy Behav Rep; 2021; 15():100417. PubMed ID: 33490948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Cases and the Molecular Profiling of a Novel Childhood Encephalopathy-Causing
    Larasati YA; Solis GP; Koval A; Griffiths ST; Berentsen R; Aukrust I; Lesca G; Chatron N; Ville D; Korff CM; Katanaev VL
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes.
    Suo GH; Zheng YQ; Wu YJ; Tang JH
    Acta Neurol Belg; 2021 Oct; 121(5):1265-1273. PubMed ID: 33590471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mechanistic review on GNAO1-associated movement disorder.
    Feng H; Khalil S; Neubig RR; Sidiropoulos C
    Neurobiol Dis; 2018 Aug; 116():131-141. PubMed ID: 29758257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AAV9-Mediated Intrastriatal Delivery of
    Roy AJ; Leipprandt JR; Patterson JR; Stoll AC; Kemp CJ; Oula ZD; Mola T; Batista AR; Sortwell CE; Sena-Esteves M; Neubig RR
    J Pharmacol Exp Ther; 2024 Jul; 390(2):250-259. PubMed ID: 38866563
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Danti FR; Galosi S; Romani M; Montomoli M; Carss KJ; Raymond FL; Parrini E; Bianchini C; McShane T; Dale RC; Mohammad SS; Shah U; Mahant N; Ng J; McTague A; Samanta R; Vadlamani G; Valente EM; Leuzzi V; Kurian MA; Guerrini R
    Neurol Genet; 2017 Apr; 3(2):e143. PubMed ID: 28357411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GNAO1 Mutations Affecting the N-Terminal α-Helix of Gαo Lead to Parkinsonism.
    Solis GP; Larasati YA; Thiel M; Koval A; Koy A; Katanaev VL
    Mov Disord; 2024 Mar; 39(3):601-606. PubMed ID: 38358016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DBS emergency surgery for treatment of dystonic storm associated with rhabdomyolysis and acute colitis in DYT-GNAO1.
    Chaib H; Schoene-Bake JC; Saryyeva A; Jack T; Hartmann H; Krauss JK
    Childs Nerv Syst; 2022 Sep; 38(9):1821-1824. PubMed ID: 35725943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Molecular Profiling in GNAO1 Permits Phenotype-Genotype Correlation.
    Lasa-Aranzasti A; Larasati YA; da Silva Cardoso J; Solis GP; Koval A; Cazurro-Gutiérrez A; Ortigoza-Escobar JD; Miranda MC; De la Casa-Fages B; Moreno-Galdó A; Tizzano EF; Gómez-Andrés D; Verdura E; Katanaev VL; Pérez-Dueñas B;
    Mov Disord; 2024 Sep; 39(9):1578-1591. PubMed ID: 38881224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxcarbazepine in bipolar disorder: a critical review of the literature.
    Mazza M; Di Nicola M; Martinotti G; Taranto C; Pozzi G; Conte G; Janiri L; Bria P; Mazza S
    Expert Opin Pharmacother; 2007 Apr; 8(5):649-56. PubMed ID: 17376019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay.
    Saitsu H; Fukai R; Ben-Zeev B; Sakai Y; Mimaki M; Okamoto N; Suzuki Y; Monden Y; Saito H; Tziperman B; Torio M; Akamine S; Takahashi N; Osaka H; Yamagata T; Nakamura K; Tsurusaki Y; Nakashima M; Miyake N; Shiina M; Ogata K; Matsumoto N
    Eur J Hum Genet; 2016 Jan; 24(1):129-34. PubMed ID: 25966631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.